Wang et al. evaluated a novel multi-component vaccine containing three SS proteins—MRP, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and dihydrolipoamide dehydrogenase (DLD)—which provided effective protection against SS2, SS7, and SS9 infections in a zebrafish model [16]. The gene discussed is DLD; the disease is infection.